MENU
+Compare
OGN
Stock ticker: NYSE
AS OF
Aug 29, 10:53 AM (EDT)
Price
$9.29
Change
+$0.12 (+1.31%)
Capitalization
2.39B

OGN Organon & Co Forecast, Technical & Fundamental Analysis

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands... Show more

OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for OGN with price predictions
Aug 28, 2025

OGN's RSI Indicator ascends from oversold territory

The RSI Indicator for OGN moved out of oversold territory on August 06, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In of the 39 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for OGN just turned positive on August 15, 2025. Looking at past instances where OGN's MACD turned positive, the stock continued to rise in of 27 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OGN advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

OGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OGN as a result. In of 67 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

OGN moved below its 50-day moving average on August 04, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OGN crossed bearishly below the 50-day moving average on August 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for OGN entered a downward trend on July 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.263) is normal, around the industry mean (9.441). OGN has a moderately low P/E Ratio (3.420) as compared to the industry average of (23.751). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). OGN's Dividend Yield (0.065) is considerably higher than the industry average of (0.027). OGN's P/S Ratio (0.381) is slightly lower than the industry average of (3.410).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

OGN is expected to report earnings to fall 6.01% to 93 cents per share on October 30

Organon & Co OGN Stock Earnings Reports
Q3'25
Est.
$0.94
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.11
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
The last earnings report on August 05 showed earnings per share of $1.00, beating the estimate of 93 cents. With 116.48K shares outstanding, the current market capitalization sits at 2.39B.
A.I.Advisor
published Dividends

OGN is expected to pay dividends on September 11, 2025

Organon & Co OGN Stock Dividends
A dividend of $0.02 per share will be paid with a record date of September 11, 2025, and an ex-dividend date of August 15, 2025. The last dividend of $0.02 was paid on June 12. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
30 Hudson Street
Phone
+1 551 430-6900
Employees
10000
Web
https://www.organon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARYNX13.70N/A
N/A
American Century Global Real Estate I
SLVAX37.59N/A
N/A
Columbia Select Large Cap Value A
CRFRX12.02N/A
N/A
Calvert Focused Value R6
ALOCX18.92N/A
N/A
Alger Mid Cap Focus C
ACIHX67.10N/A
N/A
American Century Growth G

OGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
-0.22%
BIIB - OGN
40%
Loosely correlated
-2.72%
GSK - OGN
38%
Loosely correlated
-1.18%
SNY - OGN
36%
Loosely correlated
-0.34%
JNJ - OGN
36%
Loosely correlated
-0.76%
LLY - OGN
35%
Loosely correlated
-0.30%
More